Literature DB >> 24811892

NICE's cost-effectiveness range: should it be lowered?

J P Raftery1.   

Abstract

Mesh：

Year:  2014        PMID： 24811892     DOI： 10.1007/s40273-014-0158-6

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  13 in total

1.  Multiple sclerosis risk sharing scheme: a costly failure.

Authors:  James Raftery
Journal:  BMJ       Date:  2010-06-03

2.  Does health care spending improve health outcomes? Evidence from English programme budgeting data.

Authors:  Stephen Martin; Nigel Rice; Peter C Smith
Journal:  J Health Econ       Date:  2007-12-25       Impact factor: 3.883

3.  Comparing costs and outcomes across programmes of health care.

Authors:  Stephen Martin; Nigel Rice; Peter C Smith
Journal:  Health Econ       Date:  2011-02-14       Impact factor: 3.046

4.  The Influence of Cost-Effectiveness and Other Factors on Nice Decisions.

Authors:  Helen Dakin; Nancy Devlin; Yan Feng; Nigel Rice; Phill O'Neill; David Parkin
Journal:  Health Econ       Date:  2014-09-23       Impact factor: 3.046

5.  Can the real opportunity cost stand up: displaced services, the straw man outside the room.

Authors:  Simon Eckermann; Brita Pekarsky
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

Review 6.  Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial).

Authors:  J A Michaels; W B Campbell; J E Brazier; J B Macintyre; S J Palfreyman; J Ratcliffe; K Rigby
Journal:  Health Technol Assess       Date:  2006-04       Impact factor: 4.014

7.  Using patient-reported outcome measures to estimate cost-effectiveness of hip replacements in English hospitals.

Authors:  John Appleby; Emmi Poteliakhoff; Koonal Shah; Nancy Devlin
Journal:  J R Soc Med       Date:  2013-05-28       Impact factor: 5.344

8.  Application of patient-reported outcome measures (PROMs) data to estimate cost-effectiveness of hernia surgery in England.

Authors:  Sophie Coronini-Cronberg; John Appleby; James Thompson
Journal:  J R Soc Med       Date:  2013-05-28       Impact factor: 5.344

9.  Achieving allocative efficiency in healthcare: nice in theory, not so NICE in Practice?

Authors:  Mike Paulden; Christopher McCabe; Jonathan Karnon
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

10.  Rationing of total knee replacement: a cost-effectiveness analysis on a large trial data set.

Authors:  Helen Dakin; Alastair Gray; Ray Fitzpatrick; Graeme Maclennan; David Murray
Journal:  BMJ Open       Date:  2012-01-30       Impact factor: 2.692
View more
  11 in total

1.  The Irish Cost-Effectiveness Threshold: Does it Support Rational Rationing or Might it Lead to Unintended Harm to Ireland's Health System?

Authors:  James F O'Mahony; Diarmuid Coughlan
Journal:  Pharmacoeconomics       Date:  2016-01       Impact factor: 4.981

2.  Should the Lambda (λ) Remain Silent?

Authors:  Hossein Haji Ali Afzali; Jonathan Karnon; Mark Sculpher
Journal:  Pharmacoeconomics       Date:  2016-04       Impact factor: 4.981

Review 3.  Cost-Effectiveness Thresholds: the Past, the Present and the Future.

Authors:  Praveen Thokala; Jessica Ochalek; Ashley A Leech; Thaison Tong
Journal:  Pharmacoeconomics       Date:  2018-05       Impact factor: 4.981

4.  Ethical Hurdles in the Prioritization of Oncology Care.

Authors:  Folkert de Groot; Stefano Capri; Jean-Claude Castanier; David Cunningham; Bruno Flamion; Mathias Flume; Harald Herholz; Lars-Åke Levin; Oriol Solà-Morales; Christoph J Rupprecht; Natalie Shalet; Andrew Walker; Olivier Wong
Journal:  Appl Health Econ Health Policy       Date:  2017-04       Impact factor: 2.561

5.  The marginal benefits of healthcare spending in the Netherlands: Estimating cost-effectiveness thresholds using a translog production function.

Authors:  Niek Stadhouders; Xander Koolman; Christel van Dijk; Patrick Jeurissen; Eddy Adang
Journal:  Health Econ       Date:  2019-08-30       Impact factor: 3.046

6.  Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial.

Authors:  Adrian Wells; Kirsten McNicol; David Reeves; Peter Salmon; Linda Davies; Anthony Heagerty; Patrick Doherty; Rebecca McPhillips; Rebecca Anderson; Cintia Faija; Lora Capobianco; Helen Morley; Hannah Gaffney; Gemma Shields; Peter Fisher
Journal:  Trials       Date:  2018-04-03       Impact factor: 2.279

7.  Impact of a Global Pandemic on Health Technology Assessment.

Authors:  Paula K Lorgelly; Amanda Adler
Journal:  Appl Health Econ Health Policy       Date:  2020-06       Impact factor: 2.561

Review 8.  Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations.

Authors:  Matthew Franklin; James Lomas; Gerry Richardson
Journal:  Pharmacoeconomics       Date:  2020-07       Impact factor: 4.981

9.  Cognitive aids for people with early stage dementia versus treatment as usual (Dementia Early Stage Cognitive Aids New Trial (DESCANT)): study protocol for a randomised controlled trial.

Authors:  Helen Chester; Paul Clarkson; Linda Davies; Jane Hughes; Muhammad Saiful Islam; Narinder Kapur; Martin Orrell; Julie Peconi; Rosa Pitts; Fiona Poland; Ian Russell; David Challis
Journal:  Trials       Date:  2018-10-10       Impact factor: 2.279

10.  Estimating Social Variation in the Health Effects of Changes in Health Care Expenditure.

Authors:  James Love-Koh; Richard Cookson; Karl Claxton; Susan Griffin
Journal:  Med Decis Making       Date:  2020-02-15       Impact factor: 2.583
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.